Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1990 | 09-1990 | 06-1990 | 03-1990 | 12-1989 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,365 | 185 | 569 | 398 | 1,378 |
| Receivables | 42 | 0 | 0 | 0 | 0 |
| Other current assets | 29 | 1,036 | 5 | 5 | 6 |
| TOTAL | $1,436 | $1,221 | $574 | $403 | $1,384 |
| Non-Current Assets | |||||
| PPE Net | 290 | 287 | 287 | 287 | 287 |
| Other Non-Current Assets | 4 | 4 | 301 | 301 | 309 |
| TOTAL | $294 | $291 | $588 | $588 | $596 |
| Total Assets | $1,475 | $1,267 | $925 | $762 | $1,759 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 262 | 293 | 495 | 320 | 303 |
| Accrued Expenses | 236 | 230 | 555 | 38 | 62 |
| Other current liabilities | 7 | 6 | 423 | 104 | 105 |
| TOTAL | $505 | $529 | $1,523 | $462 | $469 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 226 | 228 | 518 | 367 | 20 |
| TOTAL | $226 | $228 | $518 | $367 | $393 |
| Total Liabilities | $731 | $757 | $2,041 | $829 | $861 |
| Shareholders' Equity | |||||
| Common Shares | 160 | 159 | 146 | 137 | 137 |
| Retained earnings | -38,415 | -38,664 | -38,861 | -37,006 | -35,992 |
| Other shareholders' equity | -31 | -31 | -31 | -27 | -26 |
| TOTAL | $744 | $510 | $-1,116 | $-67 | $898 |
| Total Liabilities And Equity | $1,475 | $1,267 | $925 | $762 | $1,759 |